Clinical trial
A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With…
NCT00371566 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00371566 |
|---|---|
| Title | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer |
| Official title | A Randomized, Single Blinded, Placebo-controlled, Multi-centre, Phase II Study of Lapatinib in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma of Head and Neck |
| Intervention type | Drug |
| Interventions | Lapatinib oral tablets, Placebo |
| Enrollment | 107 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 4, 2006 |
| Last update posted | Apr 6, 2010 |
| Countries | France, Greece, India, Peru, Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: